Danaher is reportedly close to acquiring Masimo for $9.9 billion, a significant premium over Masimo’s market cap, with an announcement possibly coming as early as Tuesday. This move follows Masimo’s governance changes influenced by activist investors and has led to a 5.22% fall in Danaher’s premarket shares while Masimo’s surged 34.51%. The acquisition aims to strengthen Danaher’s position in the medical technology sector.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Danaher Nears $9.9 Billion Acquisition of Masimo Corp.
Danaher is reportedly close to acquiring Masimo for $9.9 billion, a significant premium over Masimo’s market cap, with an announcement possibly coming as early as Tuesday. This move follows Masimo’s governance changes influenced by activist investors and has led to a 5.22% fall in Danaher’s premarket shares while Masimo’s surged 34.51%. The acquisition aims to strengthen Danaher’s position in the medical technology sector.